Literature DB >> 27119539

Assessment, diagnosis and treatment of urinary incontinence in women.

Zoe Ostle1.   

Abstract

This article gives an overview of female urinary incontinence including the symptoms, diagnosis and treatment of stress urinary incontinence and overactive bladder syndrome. It summarises recent guidelines, the role of the nurse in conservative management and when a referral for specialist care is required. It aims to encourage nurses to use all opportunities to identify women who have urinary incontinence then to assess and treat urinary incontinence effectively. All patients should receive a full continence assessment. National Institute for Health and Care Excellence guidelines recommend conservative treatments including lifestyle advice, pelvic floor exercises and bladder retraining. Nurses may need to access training from their local specialist continence nurse service to enable them to provide evidence-based care. This article concludes that equitable, integrated continence services are essential to improve the quality of care for people with continence problems.

Entities:  

Keywords:  Overactive bladder syndrome; Quality of life; Role of the nurse; Stress incontinence; Urinary incontinence

Mesh:

Year:  2016        PMID: 27119539     DOI: 10.12968/bjon.2016.25.2.84

Source DB:  PubMed          Journal:  Br J Nurs        ISSN: 0966-0461


  2 in total

Review 1.  Use of Virtual Reality-Based Therapy in Patients with Urinary Incontinence: A Systematic Review with Meta-Analysis.

Authors:  Anna Rutkowska; Silvia Salvalaggio; Sebastian Rutkowski; Andrea Turolla
Journal:  Int J Environ Res Public Health       Date:  2022-05-18       Impact factor: 4.614

Review 2.  What Pelvic Floor Muscle Training Load is Optimal in Minimizing Urine Loss in Women with Stress Urinary Incontinence? A Systematic Review and Meta-Analysis.

Authors:  Esther García-Sánchez; Vicente Ávila-Gandía; Javier López-Román; Alejandro Martínez-Rodríguez; Jacobo Á Rubio-Arias
Journal:  Int J Environ Res Public Health       Date:  2019-11-08       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.